See eligibility criteria for the Medicis MediSAVE Program below.


These products are not FDA approved for combination use.

Eligibility Criteria

  1. This card is good for use only with prescriptions for specified strengths/sizes of SOLODYN® (minocycline HCl, USP) Extended Release Tablets, VANOS® (fluocinonide) Cream 0.1%, LOPROX® Shampoo (ciclopirox) 1%, or ZIANA® (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel (Medicis Products) at the time the prescription is filled by the pharmacist and dispensed to a patient. THESE PRODUCTS ARE NOT FDA APPROVED FOR COMBINATION USE.

  2. This card is good for up to three prescription fills within six months of activation for SOLODYN Tablets (55 mg, 65 mg, 80 mg, 105 mg, and 115 mg only) and ZIANA Gel (60 g tube only), where the prescription is reimbursed under private insurance or for patients who lack insurance.

  3. This card is good for one prescription fill for LOPROX Shampoo and VANOS Cream (120 g tube only) within six months of activation, only where the prescription is reimbursed under private insurance.

  4. This offer is not valid for prescriptions reimbursed in whole or in part by Medicaid, Medicare, federal or state programs (including any state prescription drug programs).

  5. Offer good only in the USA at participating retail pharmacies and cannot be redeemed at government-subsidized clinics.

  6. This offer is not valid where otherwise prohibited, taxed, or otherwise restricted. Additionnally, SOLODYN offer is not valid in Massachusetts.

  7. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.

  8. Not valid with other offers. Card has no cash value. No cash back.

  9. Maximum reimbursement limits apply. If you receive coverage through a health savings account or similar arrangement, amounts paid by the third party for your Medicis Products prescription may be deducted from your benefits limits.

  10. You understand and agree to comply with the terms and conditions of this offer as set forth above.

  11. Medicis, a division of Valeant Pharmaceuticals reserves the right to rescind, revoke or amend this offer without notice.